The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 02, 2021

Filed:

Mar. 30, 2018
Applicant:

Glovia Company Limited, Tokyo, JP;

Inventors:

Hiroaki Asou, Tokyo, JP;

Hiroaki Murase, Tokyo, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/685 (2006.01); A23L 33/105 (2016.01); A61P 25/28 (2006.01); A61K 31/7048 (2006.01); A61K 36/752 (2006.01);
U.S. Cl.
CPC ...
A61K 31/685 (2013.01); A23L 33/105 (2016.08); A61K 31/7048 (2013.01); A61K 36/752 (2013.01); A61P 25/28 (2018.01); A23V 2002/00 (2013.01);
Abstract

Provided is a composition for the treatment and/or prevention of Alzheimer's disease having an improved therapeutic or prophylactic effect together with reduced side effects. This composition for the treatment and/or prevention of Alzheimer's disease contains at least one compound selected from the group consisting of glycerophosphocholine (G) and pharmaceutically acceptable salts thereof as a first active ingredient and at least one compound selected from the group consisting of herperidin (H), narirutin (N), and pharmaceutically acceptable salts thereof as a second active ingredient. This composition promotes remyelination, promotes the activity of α-secretase, and also suppresses the expression of β-secretase.


Find Patent Forward Citations

Loading…